A detailed history of Ardsley Advisory Partners LP transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Ardsley Advisory Partners LP holds 160,000 shares of PCRX stock, worth $2.75 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
160,000
Previous 493,400 67.57%
Holding current value
$2.75 Million
Previous $14.4 Million 68.25%
% of portfolio
0.75%
Previous 2.17%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$25.5 - $31.51 $2.21 Million - $2.73 Million
86,600 Added 17.55%
580,000 $16.6 Million
Q1 2024

May 15, 2024

BUY
$27.7 - $35.48 $5.3 Million - $6.79 Million
191,400 Added 63.38%
493,400 $14.4 Million
Q4 2023

Feb 14, 2024

SELL
$26.32 - $34.31 $210,560 - $274,480
-8,000 Reduced 2.58%
302,000 $10.2 Million
Q3 2023

Nov 14, 2023

BUY
$30.68 - $40.09 $9.51 Million - $12.4 Million
310,000 New
310,000 $9.51 Million
Q3 2022

Nov 14, 2022

BUY
$51.24 - $58.89 $1.79 Million - $2.06 Million
35,000 Added 25.93%
170,000 $9.04 Million
Q2 2022

Aug 15, 2022

BUY
$51.49 - $81.64 $1.8 Million - $2.86 Million
35,000 Added 35.0%
135,000 $7.87 Million
Q1 2022

May 16, 2022

BUY
$60.03 - $76.49 $6 Million - $7.65 Million
100,000 New
100,000 $7.63 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $787M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Ardsley Advisory Partners LP Portfolio

Follow Ardsley Advisory Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Ardsley Advisory Partners LP with notifications on news.